# From Tissue Architecture To Genetic Signature: Artificial intelligence-based Analysis of Reticulin Framework and Clinical Variables Predicts Molecular Cluster in Paragangliomas

**Authors:** Eleonora Duregon, Mirko Parasiliti-Caprino, Giulia Orlando, Anna Paola Ferrero, Martina Bollati, Rute Pedrosa, Darshan Kumar, Giuseppe Giraudo, Barbara Pasini, Ezio Ghigo, Emanuela Arvat, Marco Volante, Mauro Maccario, Mauro Papotti

PMC · DOI: 10.1007/s12022-026-09904-4 · Endocrine Pathology · 2026-02-18

## TL;DR

This study uses artificial intelligence to analyze reticulin patterns in paragangliomas and predict genetic clusters, linking tissue architecture with molecular classification.

## Contribution

A novel deep learning model is introduced to predict germline cluster 1 genotype using reticulin framework analysis and clinical variables.

## Key findings

- AI-based models achieved high accuracy (AUC 0.981-0.990) in predicting germline cluster 1 genotype.
- Germline cluster 1 tumors showed distinct architectural features like intact reticulin and very small nests.
- Combining AI-derived metrics with clinical data improves pre-test genetic prediction reliability.

## Abstract

Paragangliomas (PGLs), encompassing pheochromocytomas and extra-adrenal paragangliomas, are genetically heterogeneous non-epithelial neuroendocrine neoplasms that segregate into molecular clusters with distinct biological and clinical behavior. Architectural correlates of genotype have not been systematically investigated. This study aimed to assess the reticulin framework as a potential morphologic structural surrogate of molecular background and to introduce a novel deep learning model for its spatially resolved quantitative analysis and genotype prediction. A total of 104 adrenal and extra-adrenal PGLs with complete clinical, pathological, and genetic data were retrospectively analyzed. Reticulin stain was evaluated qualitatively and quantitatively using a supervised convolutional neural network trained on expert-annotated reticulin-stained whole-slide images (WSIs) to map and quantify areas of intact framework and very small nest patterns. Two bias-reduced logistic regression models (Firth’s method) were developed to predict germline cluster 1 genotype, each combining clinical variables (age, tumor size, extra-adrenal presentation) with one artificial intelligence (AI)-derived morphometric feature-percentage of intact framework (Model-INTACT) or very small nests (Model-VSN). PGLs harboring germline cluster 1 variants occurred at a younger age, were larger, more frequently extra-adrenal, and showed significant enrichment of intact reticulin and very small nest patterns compared with cases harboring germline cluster 2 variants and sporadic cases. The supervised AI model accurately mapped and quantified these architectural features across the WSIs. Predictive models integrating AI-derived morphometrics with clinical variables achieved excellent discrimination for germline cluster 1 genotype (AUC 0.981 for Model-INTACT; AUC 0.990 for Model-VSN). Preservation of the reticulin framework, particularly with very small nests, represents a histoarchitectural correlate of pseudohypoxic PGLs. Integration of AI-based morphometric descriptors with clinical parameters enables reliable pre-test prediction of germline cluster 1 genotype, bridging conventional histopathology and molecular classification.

The online version contains supplementary material available at 10.1007/s12022-026-09904-4.

## Linked entities

- **Diseases:** paragangliomas (MONDO:0000448)

## Full-text entities

- **Genes:** SDHC (succinate dehydrogenase complex subunit C) [NCBI Gene 6391] {aka CYB560, CYBL, PGL3, PPGL3, QPS1, SDH3}, RET (ret proto-oncogene) [NCBI Gene 5979] {aka CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1}, CHGA (chromogranin A) [NCBI Gene 1113] {aka CGA, PHE5, PHES}, KIF1B (kinesin family member 1B) [NCBI Gene 23095] {aka CMT2, CMT2A, CMT2A1, HMSNII, KLP, NBLST1}, DLST (dihydrolipoamide S-succinyltransferase) [NCBI Gene 1743] {aka DLTS, KGD2, PGL7, PPGL7}, EGLN1 (egl-9 family hypoxia inducible factor 1) [NCBI Gene 54583] {aka C1orf12, ECYT3, HALAH, HIF-PH2, HIFPH2, HPH-2}, EPAS1 (endothelial PAS domain protein 1) [NCBI Gene 2034] {aka ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73}, FLCN (folliculin) [NCBI Gene 201163] {aka BHD, DENND8B, FLCL}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, HRAS (HRas proto-oncogene, GTPase) [NCBI Gene 3265] {aka C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV}, SDHAF2 (succinate dehydrogenase complex assembly factor 2) [NCBI Gene 54949] {aka C11orf79, PGL2, PPGL2, SDH5, hSDH5}, BAP1 (BRCA1 associated deubiquitinase 1) [NCBI Gene 8314] {aka HUCEP-13, KURIS, TPDS1, UBM2, UCHL2, UVM2}, INSM1 (INSM transcriptional repressor 1) [NCBI Gene 3642] {aka IA-1, IA1}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, MEN1 (menin 1) [NCBI Gene 4221] {aka MEAI, SCG2}, CA9 (carbonic anhydrase 9) [NCBI Gene 768] {aka CAIX, MN}, SUCLG2 (succinate-CoA ligase GDP-forming subunit beta) [NCBI Gene 8801] {aka G-SCS, GBETA, GTPSCS}, TMEM127 (transmembrane protein 127) [NCBI Gene 55654], ENO2 (enolase 2) [NCBI Gene 2026] {aka HEL-S-279, NSE}, AIP (AHR interacting HSP90 co-chaperone) [NCBI Gene 9049] {aka ARA9, FKBP16, FKBP37, PITA1, SMTPHN, XAP-2}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, SLTM (SAFB like transcription modulator) [NCBI Gene 79811] {aka Met}, CSDE1 (cold shock domain containing E1) [NCBI Gene 7812] {aka D1S155E, UNR}, PNMT (phenylethanolamine N-methyltransferase) [NCBI Gene 5409] {aka PENT, PNMTase}, MDH2 (malate dehydrogenase 2) [NCBI Gene 4191] {aka DEE51, EIEE51, M-MDH, MDH, MGC:3559, MOR1}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, SDHB (succinate dehydrogenase complex iron sulfur subunit B) [NCBI Gene 6390] {aka CWS2, IP, MC2DN4, PGL4, PPGL4, SDH}, SDHA (succinate dehydrogenase complex flavoprotein subunit A) [NCBI Gene 6389] {aka CMD1GG, FP, MC2DN1, NDAXOA, PGL5, PPGL5}, LDHA (lactate dehydrogenase A) [NCBI Gene 3939] {aka GSD11, HEL-S-133P, LDHM, PIG19}, EGLN2 (egl-9 family hypoxia inducible factor 2) [NCBI Gene 112398] {aka EIT-6, EIT6, HIF-PH1, HIFPH1, HPH-1, HPH-3}, VHL (von Hippel-Lindau tumor suppressor) [NCBI Gene 7428] {aka HRCA1, RCA1, VHL1, pVHL}, CDC73 (cell division cycle 73) [NCBI Gene 79577] {aka C1orf28, FIHP, HPTJT, HRPT1, HRPT2, HYX}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}, NF1 (neurofibromin 1) [NCBI Gene 4763] {aka NFNS, VRNF, WSS}, SDHD (succinate dehydrogenase complex subunit D) [NCBI Gene 6392] {aka CBT1, CII-4, CWS3, MC2DN3, PGL, PGL1}, FGFR1 (fibroblast growth factor receptor 1) [NCBI Gene 2260] {aka BFGFR, CD331, CEK, ECCL, FGFBR, FGFR-1}
- **Diseases:** adrenocortical carcinoma (MESH:D018268), endocrine and neuroendocrine tumors (MESH:D018358), necrosis (MESH:D009336), Adrenal Pheochromocytoma (MESH:D010673), endocrine tumor (MESH:D004701), papillary thyroid carcinoma (MESH:D000077273), Extra-adrenal paraganglioma (MESH:D010236), neoplastic lesions (MESH:D009062), adrenocortical adenoma (MESH:D018246), PGL (MESH:D010235), arrhythmias (MESH:D001145), hemorrhage (MESH:D006470), cortex (MESH:D000303), adrenal and (MESH:D000310), AV (MESH:D054537), Cancer (MESH:D009369), hypertension (MESH:D006973), death (MESH:D003643), inherited syndromes (MESH:D009386), non-epithelial neuroendocrine neoplasms (MESH:D009375)
- **Chemicals:** normetanephrine (MESH:D009647), metanephrine (MESH:D008676), SC (MESH:D012538), norepinephrine (MESH:D009638), eosin (MESH:D004801), methoxytyramine (MESH:C001746), tricarboxylic acid (MESH:D014233), epinephrine (MESH:D004837), catecholamine (MESH:D002395), hematoxylin (MESH:D006416), paraffin (MESH:D010232), H&amp;E (MESH:D006371)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916514/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916514/full.md

---
Source: https://tomesphere.com/paper/PMC12916514